PRESS RELEASE published on 09/10/2025 at 05:50, 4 months 23 days ago Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025 Lobe Sciences Ltd. to participate in Clusterbusters 20th Annual U.S. Patient Conference to highlight psilocin treatment for cluster headaches and discuss funding success for further research and development Patient Advocacy Conjugated Psilocin Chronic Cluster Headaches Lobe Sciences Ltd. Clusterbusters Conference
BRIEF published on 09/09/2025 at 05:55, 4 months 24 days ago Lobe Sciences nomme Marco Mastrodonato à son conseil d'administration Biopharmaceutique Nomination Au Conseil D'administration Développement Thérapeutique Sciences Du Lobe Marco Mastrodonato
BRIEF published on 09/09/2025 at 05:55, 4 months 24 days ago Lobe Sciences Appoints Marco Mastrodonato to Board Biopharmaceutical Board Appointment Therapeutic Development Lobe Sciences Marco Mastrodonato
PRESS RELEASE published on 09/09/2025 at 05:50, 4 months 24 days ago Lobe Sciences Announces the Appointment of Marco Mastrodonato to its Board of Directors Lobe Sciences Ltd. appoints Marco Mastrodonato to its Board of Directors, bringing extensive experience in pharmaceutical and biotechnology industries, enhancing global business acumen Board Of Directors Pharmaceutical Industry Lobe Sciences Ltd. Marco Mastrodonato Biotechnology Industry
BRIEF published on 08/15/2025 at 05:05, 5 months 19 days ago Lobe Sciences conclut un placement privé pour lever 341 425 $ CA Placement Privé Biopharmaceutique Offre D'actions Marché Canadien Sciences Du Lobe
BRIEF published on 08/15/2025 at 05:05, 5 months 19 days ago Lobe Sciences Concludes Private Placement to Raise CAD $341,425 Private Placement Canadian Market Biopharmaceutical Equity Offering Lobe Sciences
PRESS RELEASE published on 08/15/2025 at 05:00, 5 months 19 days ago Lobe Sciences Announces the Closing of the Previously Announced Private Placement Lobe Sciences completes non-brokered private placement totaling $341,425 CAD. Securities subject to statutory holding period. Developing treatments for rare diseases Private Placement Biopharmaceutical Therapeutics Rare Diseases Lobe Sciences
BRIEF published on 07/29/2025 at 06:15, 6 months 5 days ago Lobe Sciences annonce un placement privé pour le financement des entreprises Placement Privé Investissements Biopharmaceutique Financement Des Entreprises Sciences Du Lobe
BRIEF published on 07/29/2025 at 06:15, 6 months 5 days ago Lobe Sciences Announces Private Placement for Corporate Funding Private Placement Biopharmaceutical Investments Corporate Funding Lobe Sciences
BRIEF published on 07/29/2025 at 06:13, 6 months 5 days ago Lobe Sciences Ltd. s'associe à ArcStone pour sa stratégie de marché Partenariat Stratégique Biopharmaceutique Marchés Financiers Relations Avec Les Investisseurs Positionnement Sur Le Marché
Published on 02/03/2026 at 15:00, 4 hours 58 minutes ago Vox Royalty Announces Record 2025 Annual and Quarterly Receipts and Exceeds Annual Guidance
Published on 02/03/2026 at 14:29, 5 hours 29 minutes ago Worksport Ltd. Announces Strategic Partnership With Potomac International Partners to Accelerate Federal Government and Commercial Market Adoption of Clean Energy Ecosystem
Published on 02/03/2026 at 13:58, 6 hours ago QNX and Haleytek Join Forces to Deliver Software-Defined Audio for Volvo Cars' EX60 EV SUV
Published on 02/03/2026 at 13:30, 6 hours 28 minutes ago Alset AI's Lyken.AI Secures Cloud Compute Services Purchase Order from Leading Multinational Technology and Telecommunications Company
Published on 02/03/2026 at 13:30, 6 hours 28 minutes ago Lahontan Selects RESPEC and Kappes Cassiday to Update Santa Fe Mineral Resource Estimate and PEA
Published on 02/03/2026 at 19:44, 13 minutes ago learnd Continues Growth Trajectory with Acquisition of Safe & Sound Control Systems
Published on 02/03/2026 at 19:38, 20 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM sells non-optical analog/mixed-signal sensor business to Infineon for EUR 570 m in cash, reduces pro-forma leverage ratio to 2.5 and is creating the leader in Digital Photonics
Published on 02/03/2026 at 19:37, 21 minutes ago ams-OSRAM AG: ams OSRAM sells non-optical analog/mixed-signal sensor business to Infineon for EUR 570 m in cash, reduces pro-forma leverage ratio to 2.5 and is creating the leader in Digital Photonics
Published on 02/03/2026 at 19:06, 52 minutes ago Quarterly Activities Report for the period ending 31 December 2025
Published on 02/03/2026 at 18:39, 1 hour 19 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/03/2026 at 18:00, 1 hour 58 minutes ago Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB
Published on 02/03/2026 at 17:45, 2 hours 13 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 02/03/2026 at 17:45, 2 hours 13 minutes ago Chiffre d’affaires 2025 en croissance à 11,2 M€ (+5%)
